J&J Sold Transvaginal Mesh Implants After FDA Ordered Company To Cease Marketing

Bernstein Liebhard LLP reports that despite being ordered by the FDA to halt sales of the Gynecare Prolift transvaginal mesh implants, J&J continued to sell the devices until they were ultimately cleared nine months later. New York, New York (PRWEB) June 28, 2012 Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, reports that Johnson & Johnson (“J&J”), the manufacturer of certain transvaginal mesh implants, sold its Gynecare Prolift implants after the U.S. Food and Drug Administration (“FDA”) ordered the compan
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories